The DELUX study: development of lung volumes during extubation of preterm infants.
Leonie Plastina, Vincent D Gaertner, Andreas D Waldmann...
https://pubmed.ncbi.nlm.nih.gov/34465873/Actively Recruiting
Led by Murdoch Childrens Research Institute · Updated on 2026-08-26
134
Participants Needed
3
Research Sites
N/A
Total Duration
This research investigates breathing support methods during extubation in very preterm infants born before 30 weeks gestation. The trial compares two common extubation approaches the traditional method where nasal continuous positive airway pressure nCPAP starts after removing the breathing tube, and a newer method called prePAP where nCPAP begins before tube removal. The study aims to find out if starting nCPAP earlier reduces oxygen level drops after extubation, potentially improving respiratory stability in these fragile babies. Participants are randomly assigned to one of two groups extubation with prePAP, where nCPAP is applied via a nasal mask for 2 to 5 minutes before removing the breathing tube, or extubation without prePAP, where nCPAP starts only after tube removal. Both methods are commonly used in clinical practice. The intervention period includes a pre-extubation phase with ventilation support, followed by up to 4 hours of observation post-extubation, and a follow-up period lasting up to 7 days. During the study, infants are closely monitored for oxygen saturation and breathing support levels, with frequent measurements taken before, during, and after extubation. Researchers track oxygen levels, the need for increased breathing support, and any re-intubation events. The main outcome is the ratio of oxygen saturation to inspired oxygen concentration in the first 4 hours post-extubation. This information will help guide future care for very preterm infants needing breathing support transitions.
CONDITIONS
Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study
G
Georgia S Stephen, BBmedSc BBiomedSc(Hons)
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Murdoch Childrens Research Institute
Lead Sponsor
Western Health, Australia
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 2 to 5 minutes
Participants undergo extubation using one of two methods: starting nasal continuous positive airway pressure (nCPAP) either before or after removing the breathing tube.
1 procedure visit
Duration - Up to 4 hours
Participants are monitored closely for up to 4 hours after extubation to measure oxygen levels and breathing support needs.
Continuous monitoring during this period
Duration - Up to 7 days
Participants are followed for up to 7 days after extubation to track breathing support and any re-intubation events.
Regular assessments throughout this period
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Leonie Plastina, Vincent D Gaertner, Andreas D Waldmann...
https://pubmed.ncbi.nlm.nih.gov/34465873/Risha Bhatia, Hazel R Carlisle, Ruth K Armstrong...
https://pubmed.ncbi.nlm.nih.gov/34162692/Vincent D Gaertner, Christoph M Rüegger
https://pubmed.ncbi.nlm.nih.gov/37993322/Murdoch Childrens Research Institute
Lead Sponsor
Western Health, Australia
Collaborating Sponsor